In a surprising turn of events, most health insurers are holding steady on premiums for 2026, offering a rare sigh of relief for consumers. But here's where it gets even more intriguing: Menzis is taking a bold step by eliminating the deductible for low-income individuals in select regions, sparking a debate that could reshape how we think about healthcare accessibility. Could this be the future of equitable healthcare, or is it a risky experiment? Let’s dive in.
Thursday, 13 November 2025 - 07:42
Of the four major health insurers, three—CZ, Menzis, and VGZ—have confirmed they won’t raise premiums for their basic packages next year. In fact, VGZ is even lowering its premium slightly, while Zilveren Kruis is the lone outlier with a modest €3 increase. But the real headline-grabber is Menzis’ groundbreaking pilot program. Starting January 1, low-income clients in specific municipalities across the north and east of the country will no longer face the financial burden of the healthcare deductible. And this is the part most people miss: this supplementary policy comes at no extra cost to the insured, with municipalities identifying eligible individuals and the government reimbursing Menzis through the health insurance fund, as reported by NOS (https://nos.nl/artikel/2590259-zorgverzekeraar-menzis-stelt-voor-eigen-risico-voor-kwetsbaarste-mensen-te-schrappen).
For now, this initiative is limited to Groningen, Twente, Achterhoek, and Arnhem, where Menzis dominates the market. Municipalities in these regions have already pinpointed vulnerable residents—those receiving assistance with minimum insurance policies or energy price compensation—making them ideal candidates for this program. Dirk Jan Sloots, vice-chair of Menzis’ board of directors, explained to the broadcaster, “Municipalities already know who is vulnerable, so this targeted approach ensures those most in need receive help without unnecessary bureaucracy.”
But here’s the controversy: Menzis’ move is a direct response to the heated political debate over lowering or eliminating the deductible for everyone. Critics argue that such a broad policy would skyrocket premiums for all, potentially deterring financially vulnerable individuals from seeking necessary care. Menzis’ solution? A laser-focused approach that addresses both affordability and accessibility. “By targeting those who avoid care due to financial hardship, we’re providing direct relief without burdening the entire system,” Sloots added. “It’s cost-effective, and premiums won’t need to rise as sharply.”
This raises a thought-provoking question: Is Menzis’ model the key to balancing equity and sustainability in healthcare, or does it risk creating a patchwork system that leaves some behind? Sloots is optimistic, urging other insurers to join the initiative. “If more insurers adopt this, it could become a standardized municipal scheme,” he said. However, when approached by NOS, other insurers remained tight-lipped about Menzis’ experiment.
Premiums in Focus
Health insurers had until midnight last night to finalize their 2026 premiums, and for the first time in years, three major players—CZ, Menzis, and VGZ—have opted not to raise rates, according to NU.nl (https://www.nu.nl/economie/6375747/meevaller-voor-portemonnee-zorgpremie-niet-omhoog-bij-meeste-grote-verzekeraars.html). CZ’s popular Zorg-op-maat policy remains at €159.99 per month, while Menzis’ Basis premium holds steady at €156.25. VGZ led the pack with a €3 reduction to €154.25. Smaller insurers like DSW (https://nltimes.nl/2025/09/23/health-insurer-dsw-increasing-premiums-next-year) and Stad Holland also pledged no increases. Zilveren Kruis, however, bumped its most popular plan to €159.25, a €3 uptick.
What’s driving this stability? A windfall in the health insurance fund, which covers roughly half of the basic package costs, has played a pivotal role. Fueled by a surge in wage taxes over the past year, the fund now boasts more resources than anticipated. But as premiums stabilize, Menzis’ deductible waiver experiment looms large, challenging the status quo and inviting a critical question: Is this the future of healthcare, or a temporary fix with long-term implications?
What do you think? Is Menzis’ approach a game-changer, or does it raise more questions than it answers? Share your thoughts in the comments—let’s keep the conversation going!
